CSL:ASX
CSL Ltd
A$176.99
arrow_upward
+0.94%(+1.64) 1D
Oct 5, 4:10:08 PM GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSL...
Open
A$175.00
High
A$177.60
Low
A$175.00
Mkt. cap
84.93B
Avg. vol.
1.19M
Volume
536.61K
Dividend
1.60%
Quarterly dividend
A$0.71
Ex-dividend date
Sep 11, 2023
52-wk high
A$222.47
52-wk low
A$90.00
EPS
-A$7.72
Shares outstanding
479.88M
No. of employees
29K
Open
A$175.00
High
A$177.60
Low
A$175.00
Mkt. cap
84.93B
Avg. vol.
1.19M
Volume
536.61K
Dividend
1.60%
Quarterly dividend
A$0.71
Ex-dividend date
Sep 11, 2023
52-wk high
A$222.47
52-wk low
A$90.00
EPS
-A$7.72
Shares outstanding
479.88M
No. of employees
29K
News stories
From web sources and news partners
thebull.com.au
·
1 hour ago
CSL Strikes New Deal as Shares Enjoy Rare Period Of Consolidation
TradingView
·
1 hour ago
Australian shares edge higher as CSL deal lifts healthcare stocks
marketscreener.com
·
2 hours ago
Australian Shares Flat; CSL Partners With Alentis Therapeutics to Develop Rare Kidney, Liver Disease Drug
Investing.com
·
2 hours ago
CSL to pay up to $1.6 bln to develop rare disease drug; shares rise
Profile
CSL Limited is an Australian multinational specialty biotechnology company that researches, develops, manufactures, and markets products to treat and prevent serious human medical conditions. CSL's product areas include blood plasma derivatives, vaccines, antivenom, and cell culture reagents used in various medical and genetic research and manufacturing applications. The company was established in 1916 as Commonwealth Serum Laboratories and was wholly owned by the Australian federal government until its privatisation in 1994. Wikipedia
About CSL Ltd
CEOPaul McKenzie
Employees29K
Founded1916
HeadquartersMelbourne, Victoria, Australia
SectorBiotechnology
Websitecsl.com